Batsis is particularly concerned about the risks of sarcopenia, which can be a problem for people with excess fat as well as those who are thin and may appear frailer
In a phase 2 study in people with obesity (without T2D), retatrutide (doses 1 to 12 mg) has led to a dose-dependent WL up to 24.2% at the end of the 48-week treatment period compared to 2.1% with placebo [81]
Avoid microbiome disruptors Certain dietary and lifestyle factors actively harm the bacteria you are trying to establish: Artificial sweeteners (sucralose and saccharin have been shown to negatively affect gut bacteria composition) Excessive alcohol (disrupts gut barrier integrity and kills beneficial bacteria) Highly processed foods (low in fiber, high in additives that harm microbial diversity) Unnecessary antibiotics (the single biggest destroyer of probiotic colonization) Chronic stress (documented effects on gut microbiome composition through the gut-brain axis) People who are working to optimize their metabolic health, whether through dietary modifications alongside GLP-1 medications or through natural approaches, should prioritize removing these disruptors alongside adding beneficial interventions
GLP-1 medications arent cheap
Recognizing the clinical significance of GLP-1, JosephCareRX offers advanced treatment options known as GLP-1 receptor agonists
Given that there are no major, obvious differences in tolerability, efficacy on glycemic parameters, weight loss, or overt advantages regarding administration, it is likely that the use of LIXI in place of other GLP-1 agonists will be based on cost (79)
193lbs = 116lbs] | 9 months" loading="lazy"/>
